The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases - PubMed (original) (raw)
. 1996 Apr 26;271(17):10079-86.
doi: 10.1074/jbc.271.17.10079.
Affiliations
- PMID: 8626565
- DOI: 10.1074/jbc.271.17.10079
Free article
The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases
J M Whitelock et al. J Biol Chem. 1996.
Free article
Abstract
Perlecan is a modular heparan sulfate proteoglycan that is localized to cell surfaces and within basement membranes. Its ability to interact with basic fibroblast growth factor (bFGF) suggests a central role in angiogenesis during development, wound healing, and tumor invasion. In the present study we investigated, using domain specific anti-perlecan monoclonal antibodies, the binding site of bFGF on human endothelial perlecan and its cleavage by proteolytic and glycolytic enzymes. The heparan sulfate was removed from perlecan by heparitinase treatment, and the approximately 450-kDa protein core was digested with various proteases. Plasmin digestion resulted in a large fragment of approximately 300 kDa, whereas stromelysin and rat collagenase cleaved the protein core into smaller fragments. All three proteases removed immunoreactivity toward the anti-domain I antibody. We showed also that perlecan bound bFGF specifically by the heparan sulfate chains located on the amino-terminal domain I. Once bound, the growth factor was released very efficiently by stromelysin, rat collagenase, plasmin, heparitinase I, platelet extract, and heparin. Interestingly, heparinase I, an enzyme with a substrate specificity for regions of heparan sulfate similar to those that bind bFGF, released only small amounts of bFGF. Our findings provide direct evidence that bFGF binds to heparan sulfate sequences attached to domain I and support the hypothesis that perlecan represents a major storage site for this growth factor in the blood vessel wall. Moreover, the concerted action of proteases that degrade the protein core and heparanases that remove the heparan sulfate may modulate the bioavailability of the growth factor.
Similar articles
- Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.
Saksela O, Moscatelli D, Sommer A, Rifkin DB. Saksela O, et al. J Cell Biol. 1988 Aug;107(2):743-51. doi: 10.1083/jcb.107.2.743. J Cell Biol. 1988. PMID: 2971068 Free PMC article.
Cited by
- Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.
Mulligan-Kehoe MJ. Mulligan-Kehoe MJ. Trends Cardiovasc Med. 2013 May;23(4):114-20. doi: 10.1016/j.tcm.2012.09.009. Epub 2013 Jan 11. Trends Cardiovasc Med. 2013. PMID: 23313168 Free PMC article. Review. - Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.
Dodd T, Wiggins L, Hutcheson R, Smith E, Musiyenko A, Hysell B, Russell JC, Rocic P. Dodd T, et al. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1339-49. doi: 10.1161/ATVBAHA.113.301533. Epub 2013 Apr 18. Arterioscler Thromb Vasc Biol. 2013. PMID: 23599440 Free PMC article. - Extracellular Matrix, a Hard Player in Angiogenesis.
Mongiat M, Andreuzzi E, Tarticchio G, Paulitti A. Mongiat M, et al. Int J Mol Sci. 2016 Nov 1;17(11):1822. doi: 10.3390/ijms17111822. Int J Mol Sci. 2016. PMID: 27809279 Free PMC article. Review. - Size-fractionated heparins have differential effects on human neutrophil function in vitro.
Lever R, Lo WT, Faraidoun M, Amin V, Brown RA, Gallagher J, Page CP. Lever R, et al. Br J Pharmacol. 2007 Jul;151(6):837-43. doi: 10.1038/sj.bjp.0707298. Epub 2007 May 29. Br J Pharmacol. 2007. PMID: 17533420 Free PMC article. - Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor-Dependent Serrated Polyps in Mouse Cecum.
He Z, Chen L, Chen G, Smaldini P, Bongers G, Catalan-Dibene J, Furtado GC, Lira SA. He Z, et al. Gastroenterology. 2019 Dec;157(6):1572-1583.e8. doi: 10.1053/j.gastro.2019.08.025. Epub 2019 Aug 27. Gastroenterology. 2019. PMID: 31470007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources